UK Diabetes Market Report: 2017 - 2022
IMARC’s new report “UK Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in UK. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the UK diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the UK diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:
Focus of the Analysis:
Focus of the Analysis:
Focus of the Analysis:
What we have achieved in this report:
Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:
Focus of the Analysis:
- Historical, current and future prevalence of diabetes in UK
- Historical, current and future prevalence of type-1 and type-2 diabetes in UK
- Historical, current and future prevalence of diabetes in the urban and rural regions in UK
- Historical, current and future prevalence of diabetes among males and females in UK
- Historical, current and future prevalence of diabetes among various age groups in UK
- Historical, current and future diagnosis rates for diabetes in UK
- Historical, current and future drug treatment rates for diabetes in UK
Focus of the Analysis:
- Performance of the Oral Antidiabetics market in UK
- Performance of key classes
- Performance of key players
- Market outlook
Focus of the Analysis:
- Performance of the Insulin market in UK
- Performance of key classes
- Performance of key players
- Market outlook
1 PREFACE
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 UK DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 UK DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Strengths
7.4.2 Weaknesses
7.4.3 Opportunities
7.4.4 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 UK Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 UK Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
7.8 Competitive Landscape
7.8.1 Competitive Structure
7.8.2 Profiles of Key Players
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 UK DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 UK DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Strengths
7.4.2 Weaknesses
7.4.3 Opportunities
7.4.4 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 UK Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 UK Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
7.8 Competitive Landscape
7.8.1 Competitive Structure
7.8.2 Profiles of Key Players
LIST OF FIGURES
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2016 & 2035
Figure 4: UK: Overweight & Obese Population (in Million), 2010, 2016 & 2022
Figure 5: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 6: UK: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
Figure 7: UK: Diabetes Prevalence By Age Groups, (in %)
Figure 8: UK: Total Number of Diabetes Patients (in 000), 2009-2016
Figure 9: UK: Total Number of Diabetes Patients Forecast (in 000), 2017-2022
Figure 10: UK (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2009- 2016
Figure 11: UK (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2017-2022
Figure 12: UK (Urban & Rural): Total Number of Diabetes Patients (in 000), 2009 -2022
Figure 13: UK (Urban & Rural): Total Number of Diabetes Patients (in 000), 2017 - 2022
Figure 14: UK (Male & Female): Total Number of Diabetes Patients (in 000), 2009 - 2016
Figure 15: UK (Male & Female): Total Number of Diabetes Patients (in 000), 2017 - 2022
Figure 16: UK: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2009 - 2016
Figure 17: UK: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2017 – 2022
Figure 18: UK: Diabetes Drug Industry Overview
Figure 19: UK: Diabetes Drug Market (in Million US$), 2009 - 2016
Figure 20: UK: Diabetes Drug Market Forecast (in Million US$), 2017 – 2022
Figure 21: UK: Diabetes Drug Market: SWOT Analysis
Figure 22: UK: Diabetes Drug Market: Value Chain Analysis
Figure 23: UK: Diabetes Drug Market: Porters Five Forces Analysis
Figure 24: UK: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2009 - 2016
Figure 25: UK: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2017 - 2022
Figure 26: UK: Oral Antidiabetics Market: (in Million US$), 2009 - 2016
Figure 27: UK: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009 & 2016
Figure 28: UK: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 29: UK: Oral Antidiabetics Market: (in Million US$), 2017 - 2022
Figure 30: UK: Insulin Market, (in Million US$), 2009 - 2016
Figure 31: UK: Breakup of Insulin Market by Class (in %)
Figure 32: UK: Insulin Market: Sales Share of Key Players (in %)
Figure 33: UK: Insulin Market Forecast (in Million US$), 2017 - 2022
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2016 & 2035
Figure 4: UK: Overweight & Obese Population (in Million), 2010, 2016 & 2022
Figure 5: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 6: UK: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
Figure 7: UK: Diabetes Prevalence By Age Groups, (in %)
Figure 8: UK: Total Number of Diabetes Patients (in 000), 2009-2016
Figure 9: UK: Total Number of Diabetes Patients Forecast (in 000), 2017-2022
Figure 10: UK (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2009- 2016
Figure 11: UK (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2017-2022
Figure 12: UK (Urban & Rural): Total Number of Diabetes Patients (in 000), 2009 -2022
Figure 13: UK (Urban & Rural): Total Number of Diabetes Patients (in 000), 2017 - 2022
Figure 14: UK (Male & Female): Total Number of Diabetes Patients (in 000), 2009 - 2016
Figure 15: UK (Male & Female): Total Number of Diabetes Patients (in 000), 2017 - 2022
Figure 16: UK: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2009 - 2016
Figure 17: UK: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2017 – 2022
Figure 18: UK: Diabetes Drug Industry Overview
Figure 19: UK: Diabetes Drug Market (in Million US$), 2009 - 2016
Figure 20: UK: Diabetes Drug Market Forecast (in Million US$), 2017 – 2022
Figure 21: UK: Diabetes Drug Market: SWOT Analysis
Figure 22: UK: Diabetes Drug Market: Value Chain Analysis
Figure 23: UK: Diabetes Drug Market: Porters Five Forces Analysis
Figure 24: UK: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2009 - 2016
Figure 25: UK: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2017 - 2022
Figure 26: UK: Oral Antidiabetics Market: (in Million US$), 2009 - 2016
Figure 27: UK: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009 & 2016
Figure 28: UK: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 29: UK: Oral Antidiabetics Market: (in Million US$), 2017 - 2022
Figure 30: UK: Insulin Market, (in Million US$), 2009 - 2016
Figure 31: UK: Breakup of Insulin Market by Class (in %)
Figure 32: UK: Insulin Market: Sales Share of Key Players (in %)
Figure 33: UK: Insulin Market Forecast (in Million US$), 2017 - 2022
LIST OF TABLES
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2016 & 2035
Table 3: UK: Overweight & Obesity Statistics, 2010, 2016 & 2022
Table 4: UK: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
Table 5: UK: Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 6: UK (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 7: UK (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 8: UK (Male & Female): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 9: UK: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2009, 2016 & 2022
Table 10: UK: Diabetes Drug Market: Competitive Structure
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2016 & 2035
Table 3: UK: Overweight & Obesity Statistics, 2010, 2016 & 2022
Table 4: UK: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
Table 5: UK: Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 6: UK (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 7: UK (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 8: UK (Male & Female): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
Table 9: UK: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2009, 2016 & 2022
Table 10: UK: Diabetes Drug Market: Competitive Structure
